stride study semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial Evaluating the Cardiovascular Benefits of – Semaglutide Improves Walking Capacity in

Clinical trials use strict protocols, monitor patients closely, and exclude people with severe pre-existing GERD

But it hasnt been demonstrated, says Blundell, who is working with a food company to develop foods that are more palatable for people on GLP-1 medications

Joshua Silva, MD Nov 7, 2025 13 min read Updated: Apr 17 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD As GLP-1 and GLP-1/GIP medications such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) continue to transform medical weight management, one question comes up repeatedly: Do these medications cause muscle lossor even muscle wasting

What Causes GLP-1 Injection Site Reactions Understanding the reasons behind injection site reactions can help reduce their occurrence

Abandoning titration principles Split dosing does not eliminate the need for gradual dose escalation